iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
22,606.20
-
High
22,752.20
-
Low
22,463.00
-
Prev Close
22,570.80
-
Dividend Yeild
0.59%
-
P/E
37.61
Nifty Pharma Chart
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
Company | Market Cap | Market Price | Volume | Sector |
---|---|---|---|---|
Abbott India Ltd | ₹60618 Cr |
₹28433.55
(1.44%)
|
15038 | Pharmaceuticals |
Cipla Ltd | ₹120235 Cr |
₹1488.9
(0.87%)
|
1683065 | Pharmaceuticals |
J B Chemicals & Pharmaceuticals Ltd | ₹29390 Cr |
₹1891.9
(0.65%)
|
207435 | Pharmaceuticals |
Dr Reddys Laboratories Ltd | ₹108706 Cr |
₹6514.7
(0.61%)
|
362830 | Pharmaceuticals |
Lupin Ltd | ₹98274 Cr |
₹2156.7
(0.37%)
|
1367786 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
Sector Name | Percentage Change |
---|---|
Infrastructure Investment Trusts | 0.24 |
Under Performing
Sector Name | Percentage Change |
---|---|
Diamond, Gems and Jewellery | -3.16 |
IT - Hardware | -2.32 |
Leather | -1.73 |
Ceramic Products | -2.4 |
NIFTY Pharma
The pharma industry’s performance is depicted in the NIFTY Pharma Index. 20 NSE-listed companies are included in the Index (NSE).
The level of the NIFTY Pharma Index shows the overall free float market valuation of all the companies included in the benchmark with a specific base market cap value. This index is calculated by using the free float market capitalization approach.
The NIFTY Pharma Index is utilized for several things, including creating structured products, ETFs, and index funds, as well as benchmarking investment portfolios.
The index was introduced in July 2005, with a reference level of 1000 and a baseline date of January 1st, 2001. The index is recalibrated every two years.
NIFTY Pharma Scrip Selection Criteria
● The companies under evaluation must be NIFTY 500 members.
● A shortfall amount of stocks will be chosen from the world of securities classified within the leading 800, predicated both on total daily turnover and daily total full market capitalization.
● Businesses must be engaged with the pharmaceutical industry.
● The company’s investing velocity in the previous six months must have been at least 90%.
● The company must have a six-month listing record. If a firm launches an IPO and meets the standard qualifying conditions for the index for a 3-month term rather than a period of 6 months, it will become qualified for inclusion within the index.
● Depending on the companies’ free-float market capitalization, the final 20 companies will be chosen.
● When making the final decision, priority will be given to firms that can be traded in the futures and options part of the NSE.
Other Indices
Indices Name | Price | Price Change (% change) |
---|---|---|
India VIX | 14.6325 | 0.66 (4.74%) |
Nifty 10 Yr Benchmark G-Sec | 2410.5 | -2.55 (-0.11%) |
Nifty 10 Yr Benchmark G-Sec (Clean Price) | 887.78 | -1.11 (-0.12%) |
Nifty 100 | 25022.2 | -253.3 (-1%) |
Nifty 100 Equal Weight | 32142.4 | -507 (-1.55%) |
Faqs
Which is the current best pharma company in India?
Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization.
How do I calculate NIFTY Pharma?
Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing, and no separate stock should have a weightage greater than 33%. Index Rebalancing: The index is recalibrated every two years.
How many companies are available in the NIFTY 50 index?
The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd., and Sun Pharmaceuticals Ltd.
Is it risky to invest in pharma stocks?
Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
Should I start investing in pharmaceutical stocks?
Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
What is the cause behind the impulsive growth of the pharma sector?
Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
What are the few major uses of NIFTY Pharma?
There are several uses of NIFTY Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.
Latest News
- Oct 25, 2024
Summary Godavari Biorefineries IPO has closed with a moderate response from investors, achieving a final subscription of 1.87 times by 25th October 2024 at 5:19:07 PM (Day 3). The public issue witnessed varied demand across investor categories. The Qualified Institutional Buyers (QIB) category led with a subscription of 2.76 times. The Retail Investors segment showed decent interest with 1.76 times subscription.
- Oct 25, 2024
Afcons Infrastructure's initial public offering (IPO) has received modest investor interest on its opening day. The IPO witnessed cautious demand, resulting in a 0.08 times subscription by 2:01:10 PM on day one. This initial response indicates measured investor sentiment towards Afcons Infrastructure's shares at the start of the subscription period.
- Oct 25, 2024
Afcons Infrastructure IPO, valued at ₹5,430 crore, is now open for investors, offering a chance to participate in one of India’s major infrastructure companies. This IPO appeals to investors seeking to capitalise on India’s ongoing infrastructure growth, especially given Afcons’ extensive experience as part of the Shapoorji Pallonji Group. Overview of Afcons Infrastructure IPO
- Oct 25, 2024
Afcons Infrastructure IPO saw a strong anchor allocation response, with 36.35% of the total IPO size subscribed by anchor investors. Out of 9,63,35,319 shares on offer, anchors picked up 3,50,21,597 shares, demonstrating robust market confidence. The anchor allocation details were reported to the stock exchanges on 24th October 2024, just ahead of the IPO opening on 25th October 2024.
Latest Blogs
Nifty Prediction for 28th October Our markets witnessed sharp correction throughout the week and a broad market sell-off was seen leading to nervousness amongst market participants. Nifty ended the week around 24200 with a weekly loss of over two and a half percent.
- Oct 25, 2024
Swing Trading Stocks for the Week iJoin the club of lakhs of tech savvy investors!
- Oct 25, 2024
Highlights 1. ITC's share price has increased over 2.67% year to date in 2024 including today’s 1.88% gain. 2. ITC's financial performance has increased over the past year with operating profit Increasing from ₹25,915 crores in March 2023 to ₹27,302 crores till TTM 2024. 3. ITC's quarterly earnings report highlighted a decline in net profit in the September quarters.
- Oct 25, 2024
What is Muhurat Trading? According to the Hindu calendar, muhurat trade is a one-hour trading period that happens on Diwali evening. A "muhurat" is an auspicious period when merchants and investors buy and sell shares in the hopes of gaining wealth and good fortune for the upcoming year. Muhurat trading times are set by stock exchanges a few days before to Diwali.
- Oct 25, 2024